Marie Lange
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Marie Lange has a total of 27 co-authors. Here are the top co-authors by number of shared publications:
- Florence Joly
Medical Oncology Department, Centre Francois Baclesse, Caen, France
5 shared publications - Bénédicte Giffard
Université de Caen Normandie, INSERM, EPHE-PSL, PSL University, CHU de Caen, GIP Cyceron, U1077, NIMH, Caen, France
3 shared publications - Francis Eustache
Normandie Univ, UNICAEN, PSL Research University, EPHE, INSERM, U1077, CHU de Caen, GIP Cyceron, Neuropsychologie et Imagerie de la Mémoire Humaine, 14000 Caen, France
3 shared publications - Bénédicte Clarisse
Unité de Recherche Clinique, Centre François Baclesse, Caen, France
2 shared publications - Olivier Rigal
Centre Henri Becquerel, Rouen, France
2 shared publications - Sabine Noal
Unité de Recherche Clinique, Centre François Baclesse, Caen, France; Comité Sein, Centre François Baclesse, Caen, France
2 shared publications
Latest Publications
- Open Access
The Prostate Cancer Therapy Enzalutamide Compared with Abiraterone Acetate/Prednisone Impacts Motivation for Exploration, Spatial Learning and Alters Dopaminergic Transmission in Aged Castrated Mice
Cognitive side effects after cancer treatment threatening quality of life (QoL) constitute a major challenge in oncology. Abiraterone acetate plus prednisone (AAP) and enzalutamide (ENZ) are examples of next-generation therapy (NGT) administered to metastatic castration-resistant prostate cancer (mCRPC) patients. NGT significantly improved mCRPC overall survival but neurological side effects such as fatigue and cognitive impairment were reported. We developed a behavioral 17 months-aged and castrated mouse model receiving per os AAP or ENZ for 5 days per week for six consecutive weeks. ENZ exposure reduced spontaneous activity and exploratory behavior associated with a decreased tyrosine hydroxylase (TH)-dopaminergic activity in the substantia nigra pars compacta and the ventral tegmental area. A decrease in TH+-DA afferent fibers and Phospho-DARPP32-related dopaminergic neuronal activities in the striatum and the ventral hippocampus highlighted ENZ-induced dopaminergic regulation within the nigrostriatal and mesolimbocortical pathways. ENZ and AAP treatments did not substantially modify spatial learning and memory performances, but ENZ led to a thygmotaxis behavior impacting the cognitive score, and reduced c-fos-related activity of NeuN+-neurons in the dorsal hippocampus. The consequences of the mCRPC treatment ENZ on aged castrated mouse motivation to exploration and cognition should make reconsider management strategy of elderly prostate cancer patients.
Open AccessThe Prostate Cancer Therapy Enzalutamide Compared with Abiraterone Acetate/Prednisone Impacts Motivation for Exploration, Spatial Learning and Alters Dopaminergic Transmission in Aged Castrated Mice
Cognitive side effects after cancer treatment threatening quality of life (QoL) constitute a major challenge in oncology. Abiraterone acetate plus prednisone (AAP) and enzalutamide (ENZ) are examples of next-generation therapy (NGT) administered to metastatic castration-resistant prostate cancer (mCRPC) patients. NGT significantly improved mCRPC overall survival but neurological side effects such as fatigue and cognitive impairment were reported. We developed a behavioral 17 months-aged and castrated mouse model receiving per os AAP or ENZ for 5 days per week for six consecutive weeks. ENZ exposure reduced spontaneous activity and exploratory behavior associated with a decreased tyrosine hydroxylase (TH)-dopaminergic activity in the substantia nigra pars compacta and the ventral tegmental area. A decrease in TH+-DA afferent fibers and Phospho-DARPP32-related dopaminergic neuronal activities in the striatum and the ventral hippocampus highlighted ENZ-induced dopaminergic regulation within the nigrostriatal and mesolimbocortical pathways. ENZ and AAP treatments did not substantially modify spatial learning and memory performances, but ENZ led to a thygmotaxis behavior impacting the cognitive score, and reduced c-fos-related activity of NeuN+-neurons in the dorsal hippocampus. The consequences of the mCRPC treatment ENZ on aged castrated mouse motivation to exploration and cognition should make reconsider management strategy of elderly prostate cancer patients.
- 1 January 2016
- Published by Springer Nature
- p. 11-22
Cognitive Function During and After Treatment in Elderly Ovarian Cancer Patients
- 1 January 2016
- Published by Springer Nature
- p. 11-22
Cognitive Function During and After Treatment in Elderly Ovarian Cancer Patients
- 1 September 2014
- Published by Elsevier in European Journal of Cancer
- Vol. 50 (13) , 2181-2189
Baseline cognitive functions among elderly patients with localised breast cancer
- 1 September 2014
- Published by Elsevier in European Journal of Cancer
- Vol. 50 (13) , 2181-2189
Baseline cognitive functions among elderly patients with localised breast cancer
- 1 July 2014
- Published by Elsevier in Cancer Treatment Reviews
- Vol. 40 (6) , 810-817
Cognitive dysfunctions in elderly cancer patients: A new challenge for oncologists
- 1 July 2014
- Published by Elsevier in Cancer Treatment Reviews
- Vol. 40 (6) , 810-817
Cognitive dysfunctions in elderly cancer patients: A new challenge for oncologists
- 28 February 2011
- Published by PiscoMed Publishing Pte. Ltd. in Psycho-Oncologie
- Vol. 5 (1) , 3-10
Impact de la chimiothérapie adjuvante sur les fonctions cognitives dans le cancer du sein: revue de la littérature
Des études ont montré que le traitement par chimiothérapie adjuvante du cancer du sein peut être associé à des déficits cognitifs légers. Ces troubles ont un impact négatif sur la qualité de vie des patientes, et la compréhension de leur origine et des processus altérés est actuellement un des enjeux importants de ce nouveau thème de recherche. Peu d’études ont été réalisées auprès de patientes âgées, alors que l’âge est le facteur de risque le plus important pour ce cancer. Cet article propose une synthèse de la littérature et discute de l’incidence de tels troubles chez les patients âgés. Understanding the neuropsychological consequences of chemotherapy is a major challenge. Studies have shown that treatment with adjuvant chemotherapy for breast cancer may be associated with mild cognitive deficits. These disorders have a negative impact on the quality of life of patients. Few studies have been conducted with elderly patients, although the age factor is the biggest risk for this cancer. This article offers an overview of the literature and discusses the impact of such impairments in the elderly.
- 28 February 2011
- Published by PiscoMed Publishing Pte. Ltd. in Psycho-Oncologie
- Vol. 5 (1) , 3-10
Impact de la chimiothérapie adjuvante sur les fonctions cognitives dans le cancer du sein: revue de la littérature
Des études ont montré que le traitement par chimiothérapie adjuvante du cancer du sein peut être associé à des déficits cognitifs légers. Ces troubles ont un impact négatif sur la qualité de vie des patientes, et la compréhension de leur origine et des processus altérés est actuellement un des enjeux importants de ce nouveau thème de recherche. Peu d’études ont été réalisées auprès de patientes âgées, alors que l’âge est le facteur de risque le plus important pour ce cancer. Cet article propose une synthèse de la littérature et discute de l’incidence de tels troubles chez les patients âgés. Understanding the neuropsychological consequences of chemotherapy is a major challenge. Studies have shown that treatment with adjuvant chemotherapy for breast cancer may be associated with mild cognitive deficits. These disorders have a negative impact on the quality of life of patients. Few studies have been conducted with elderly patients, although the age factor is the biggest risk for this cancer. This article offers an overview of the literature and discusses the impact of such impairments in the elderly.